The answer depends on your overall health, the specific medication you're taking, and individual blood bank policies rather than the medication itself
In general, acceptable as long as you have been medically evaluated and treated, have no current (within the last 6 months) heart related symptoms such as chest pain and have no limitations or restrictions on your normal daily activities
Most people report appetite suppression returning by week 2-3 on tirzepatide, even at the 2.5 mg dose, because the GIP receptor activation adds effects that semaglutide alone could not provide
Some clinicians note that tirzepatide can slow gastric emptying more substantially than some semaglutide formulations at equivalent doses, so additional confirmation that your stomach has cleared before sedation may be requested
Keep in mind, its always best to verify directly with your local center